0001181431-12-017850.txt : 20120315 0001181431-12-017850.hdr.sgml : 20120315 20120315212747 ACCESSION NUMBER: 0001181431-12-017850 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120313 FILED AS OF DATE: 20120315 DATE AS OF CHANGE: 20120315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Peroutka Stephen J CENTRAL INDEX KEY: 0001534573 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33438 FILM NUMBER: 12695608 MAIL ADDRESS: STREET 1: 24660 CABRILLO STREET CITY: CARMAL STATE: CA ZIP: 93923 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NeurogesX Inc CENTRAL INDEX KEY: 0001385830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943307935 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2215 BRIDGEPOINTE PARKWAY STREET 2: SUITE 200 CITY: SAN MATEO STATE: CA ZIP: 94404 BUSINESS PHONE: 650-358-3300 MAIL ADDRESS: STREET 1: 2215 BRIDGEPOINTE PARKWAY STREET 2: SUITE 200 CITY: SAN MATEO STATE: CA ZIP: 94404 4 1 rrd339011.xml FORM 4 X0304 4 2012-03-13 0 0001385830 NeurogesX Inc NGSX 0001534573 Peroutka Stephen J C/O NEUROGESX, INC., 2215 BRIDGEPOINTE PARKWAY, SUITE 200 SAN MATEO CA 94404 0 1 0 0 Vice President and CMO Stock Option (right to buy) 0.48 2012-03-13 4 A 0 175000 0 A 2013-03-13 2022-03-13 Common Stock 175000 175000 D Stock Option (right to buy) 0.48 2012-03-13 4 A 0 175000 0 A 2014-03-13 2022-03-13 Common Stock 175000 175000 D The option grant shares are granted under the 2007 Stock Plan and shall vest as follows: one-hundred percent (100%) of the total number of shares subject to the option grant shall become exercisable on March 13, 2013, subject to the grantee's continued service relationship with the Company The option grant shares are granted under the 2007 Stock Plan and shall vest as follows: one-hundred percent (100%) of the total number of shares subject to the option grant shall become exercisable on March 13, 2014 or upon the attainment of the Company's milestone; such milestone must be attained by December 31, 2012 or the shares shall not become exercisable until March 13, 2014, subject to the grantee's continued service relationship with the Company. /s/ Stephen Ghiglieri as Attorney in Fact for Stephen J. Peroutka 2012-03-15